Elan Corp.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3167680002
JPY
719.00
23 (3.3%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
14,762.99
14,709.47
13,898.78
13,406.87
13,433.56
12,666.31
12,002.76
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
14,762.99
14,709.47
13,898.78
13,406.87
13,433.56
12,666.31
12,002.76
Raw Material Cost
11,365.11
11,472.86
11,028.14
10,633.75
10,439.71
9,940.02
9,384.55
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
12.74
26.66
13.90
10.47
7.99
0.00
0.00
Selling and Distribution Expenses
1,956.24
2,005.99
1,904.32
1,885.16
1,810.94
1,880.00
1,817.56
Other Expenses
-1.27
-2.67
-1.39
-1.05
-0.80
0.00
0.00
Total Expenditure (Excl Depreciation)
13,321.35
13,478.86
12,932.46
12,518.91
12,250.66
11,820.02
11,202.11
Operating Profit (PBDIT) excl Other Income
1441.6
1230.6
966.3
888
1182.9
846.3
800.6999999999999
Other Income
-18.74
-47.91
20.67
-9.33
0.56
-1.85
-57.06
Operating Profit (PBDIT)
1,515.38
1,444.46
1,335.48
1,246.64
1,559.58
1,233.52
992.16
Interest
12.74
26.66
13.90
10.47
7.99
0.00
0.00
Exceptional Items
0.00
3.71
3.50
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
3,397.88
3,236.61
2,870.65
2,773.12
2,993.84
2,726.29
2,618.22
Depreciation
92.48
261.75
348.48
368.01
376.12
386.28
243.11
Profit Before Tax
1,410.16
1,159.76
976.60
868.17
1,175.47
847.25
749.04
Tax
470.63
384.95
307.94
288.24
372.32
324.76
242.17
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
949.86
745.23
655.33
567.19
800.06
522.48
506.87
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
949.86
745.23
655.33
567.19
800.06
522.48
506.87
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-10.33
29.59
13.33
12.74
3.09
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
939.53
774.82
668.66
579.93
803.14
522.48
506.87
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
14,518.19
14,443.28
13,540.95
12,862.04
12,372.13
12,501.85
11,880.08
Earnings per share (EPS)
15.7
12.32
10.84
9.38
13.23
8.64
8.38
Diluted Earnings per share
15.7
12.32
10.84
9.38
13.23
8.64
8.38
Operating Profit Margin (Excl OI)
9.77%
8.37%
6.95%
6.62%
8.81%
6.7%
6.72%
Gross Profit Margin
10.18%
9.66%
9.53%
9.22%
11.55%
9.74%
8.27%
PAT Margin
6.43%
5.07%
4.72%
4.23%
5.96%
4.12%
4.22%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is 9.90% vs 16.95% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is 16.98% vs 10.50% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is -1.60% vs 30.14% in Mar 2025

stock-summary

Interest

YoY Growth in quarter ended Mar 2026 is 58.75% vs 0.00% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025

Compare Quarterly Results Of Elan Corp. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
14,762.99
19,233.00
-4,470.01
-23.24%
Other Operating Income
0.00
0.00
0.00
Total Operating income
14,762.99
19,233.00
-4,470.01
-23.24%
Raw Material Cost
11,365.11
9,893.00
1,472.11
14.88%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
12.74
53.00
-40.26
-75.96%
Selling and Distribution Expenses
1,956.24
5,377.00
-3,420.76
-63.62%
Other Expenses
-1.27
164.90
-166.17
-100.77%
Total Expenditure (Excl Depreciation)
13,321.35
16,972.00
-3,650.65
-21.51%
Operating Profit (PBDIT) excl Other Income
1,441.64
2,261.00
-819.36
-36.24%
Other Income
-18.74
-15.00
-3.74
-24.93%
Operating Profit (PBDIT)
1,515.38
3,016.00
-1,500.62
-49.76%
Interest
12.74
53.00
-40.26
-75.96%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
3,397.88
9,340.00
-5,942.12
-63.62%
Depreciation
92.48
770.00
-677.52
-87.99%
Profit Before Tax
1,410.16
2,194.00
-783.84
-35.73%
Tax
470.63
547.00
-76.37
-13.96%
Provisions and contingencies
0
0
0.00
Profit After Tax
949.86
1,678.00
-728.14
-43.39%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
949.86
1,678.00
-728.14
-43.39%
Share in Profit of Associates
0
0
0.00
Minority Interest
-10.33
-31.00
20.67
66.68%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
939.53
1,647.00
-707.47
-42.96%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
14,518.19
68,738.00
-54,219.81
-78.88%
Earnings per share (EPS)
15.70
59.09
-43.39
-73.43%
Diluted Earnings per share
15.70
59.09
-43.39
-73.43%
Operating Profit Margin (Excl OI)
9.77%
11.76%
0.00
-1.99%
Gross Profit Margin
10.18%
15.41%
0.00
-5.23%
PAT Margin
6.43%
8.72%
0.00
-2.29%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,476.30 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 0.36% vs 5.83% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 9.90% vs 16.95% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 93.95 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 21.26% vs 15.87% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 16.98% vs 10.50% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 153.41 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 2.79% vs 13.51% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -1.60% vs 30.14% in Mar 2025

Quarterly - Interest
Interest 1.27 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -52.43% vs 92.09% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 58.75% vs 0.00% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.77%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025